$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma

Journal of cancer research and clinical oncology, v.118 no.8, 1992년, pp.609 - 614  

Koyama, Shohei ,  Ebihara, Tsugio ,  Fukao, Katashi

초록이 없습니다.

참고문헌 (42)

  1. Lancet M Billaud 2 1327 1987 10.1016/S0140-6736(87)91214-1 Billaud M, Calender A, Seigneurine JM, Leonoir GM (1987) LFA-1, LFA-3, and ICAM-1 expression in Burkitt's lymphoma. Lancet 2:1327?1328 

  2. Nature PJ Björkman 329 512 1987 10.1038/329512a0 Björkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512?518 

  3. J Clin Immunol LT Clement 131 2296 1984 Clement LT, Dagg HD, Landy A (1984) Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2a+ suppressor cells. J Clin Immunol 131:2296?2300 

  4. Virchows Arch [A] T Degener 412 315 1988 10.1007/BF00750257 Degener T, Momburg F, Möller P (1988) Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma. Virchows Arch [A] 412:315?322 

  5. Eur J Immunol GJ Dougherty 18 35 1988 10.1002/eji.1830180107 Dougherty GJ, Murdoch S, Hogg N (1988) The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 18:35?39 

  6. J Immunol J Doukas 145 1088 1990 10.4049/jimmunol.145.4.1088 Doukas J, Pober JS (1990) Lymphokine-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-? and increasing EC class I MHC and intercellular adhesion molecule-1 expression. J Immunol 145:1088?1098 

  7. Nature A Doyle 330 256 1987 10.1038/330256a0 Doyle A, Strominger J (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256?259 

  8. J Exp Med A Doyle 161 1135 1985 10.1084/jem.161.5.1135 Doyle A, Martin WJ, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttita F, Mulshine J, Bunn P, Minna J (1985) Markedly decreased expression of class I histocompatibility antigens, protein and m RNA in human small cell lung cancer. J Exp Med 161:1135?1151 

  9. J Immunol ML Dustine 137 245 1986 10.4049/jimmunol.137.1.245 Dustine ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL 1 and interferon-?: tissue distribution, biochemistry, and function of a natural adhesion molecule (ICAM-1). J Immunol 137:245?254 

  10. Tohoku J Exp Med T Ebihara 162 49 1990 10.1620/tjem.162.49 Ebihara T, Koyama S (1990) Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma. Tohoku J Exp Med 162:49?63 

  11. Cancer Immunol Immunother T Ebihara 28 218 1989 10.1007/BF00204992 Ebihara T, Koyama S, Fukao K, Osuga T (1989) Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma. Cancer Immunol Immunother 28:218?224 

  12. Cancer T Ebihara 66 923 1990 10.1002/1097-0142(19900901)66:5<923::AID-CNCR2820660518>3.0.CO;2-R Ebihara T, Fukao K, Koyama S (1990) Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma. Cancer 66:923?929 

  13. Eur J Cancer T Ebihara 27 1654 1991 10.1016/0277-5379(91)90439-K Ebihara T, Sakai N, Koyama S (1991) Suppression by sorted CD8+ CD11b? cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma. Eur J Cancer 27:1654?1657 

  14. Br Med Bull H Festenstein 43 217 1987 10.1093/oxfordjournals.bmb.a072172 Festenstein H (1987) The biological consequences of altered MHC expression of tumour. Br Med Bull 43:217?227 

  15. Hämmerling GJ, Klar D, Katzaw S, Segal S, Feldman M, Wallich R, Hämmerling A (1986) Manipulation of metastasis and tumor growth by transfection with histocompatibility class I antigens. J Immunogenet 153?157 

  16. Biochim Biophys Acta GJ Hämmerling 907 245 1987 Hämmerling GJ, Klar D, Pülm W, Momburg F, Moldenhauer G (1987) The influence of major histocompatibility complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta 907:245?259 

  17. J Immunol CV Harding 142 12 1989 10.4049/jimmunol.142.1.12 Harding CV, Unaue ER (1989) Antigen processing and intercellular Ia: possible roles of endocytosis and protein synthesis in Ia function. J Immunol 142:12?19 

  18. proc Natl Acad Sci USA JP Johnson 86 641 1989 10.1073/pnas.86.2.641 Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmüller G (1989) De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. proc Natl Acad Sci USA 86:641?644 

  19. J Immunol J Koide 144 32 1990 10.4049/jimmunol.144.1.32 Koide J, Engelman EG (1990) Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. J Immunol 144:32?40 

  20. Int J Cancer S Koyama 27 829 1981 10.1002/ijc.2910270615 Koyama S, Fujimoto S, Tada T, Sakita T (1981) Effect of bacillus Calmette-Guerin cell wall skeleton on the induction of the cytotoxic and suppressor T cells against syngeneic tumor in the mouse. Int J Cancer 27:829?835 

  21. Cancer Res S Koyama 42 3215 1982 Koyama S, Yoshioka T, Sakita T (1982) Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant. Cancer Res 42:3215?3219 

  22. Cancer Res S Koyama 47 4667 1987 Koyama S, Mukai R, Fukao K, Arimura H, Iwasaki Y, Osuga T (1987) Monoclonal antibody against human gallbladder carcinoma-associated antigen. Cancer Res 47:4667?4673 

  23. Jpn J Cancer Res S Koyama 80 150 1989 10.1111/j.1349-7006.1989.tb02283.x Koyama S, Ebihara T, Fukao K, Osuga T (1989) Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients. Jpn J Cancer Res 80:150?157 

  24. Cancer Res M Maio 49 2980 1989 Maio M, Gulwani B, Langer A, Kerbel RS, Duigou GJ, Fisher PB, Ferrone S (1989) Modulation by interferons of HLA antigen, high-molecular-weight melanoma-associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res 49:2980?2987 

  25. Cell SD Marlin 51 813 1987 10.1016/0092-8674(87)90104-8 Marlin SD, Springer TA (1987) Purified intercellular adhesion molecule 1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 51:813?819 

  26. Proc Natl Acad Sci USA SC Meuer 79 4395 1982 10.1073/pnas.79.14.4395 Meuer SC, Schlossman SF, Reinherz EL (1982) Clonal analysis of human cytotoxis T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci USA 79:4395?4399 

  27. Int J Cancer P Möller 40 32 1987 10.1002/ijc.2910400107 Möller P, Herrman B, Moldenhauer G, Momburg F (1987) Defective expression of MHC class I antigens is frequent in B cell lymphomas of high-grade malignancy. Int J Cancer 40:32?39 

  28. Nature C Morimoto 330 479 1987 10.1038/330479a0 Morimoto C, Rudd CE, Letven NL, Schlossman SF (1987) A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 330:479?482 

  29. Int J Cancer R Mortarini 45 334 1990 10.1002/ijc.2910450221 Mortarini R, Belli F, Parmiani G, Anichini A (1990) Cytokine-mediated modulation of HLA class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL 1?, rTNF-?, rIFN-?, rIL 4 and their combinations. Int J Cancer 45:334?341 

  30. Cancer Res P Natali 50 1271 1990 Natali P, Nicotra MR, Cavaliere R, Biotti A, Romano G, Temponi M, Ferrone S (1990) Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 50:1271?1278 

  31. Nature AM Norment 336 79 1988 10.1038/336079a0 Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR (1988) Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79?81 

  32. Nature JG Nuchterm 343 74 1990 10.1038/343074a0 Nuchterm JG, Biddison WE, Klausner RD (1990) Class-II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74?76 

  33. Scand J Immunol M Patarroyo 30 129 1989 10.1111/j.1365-3083.1989.tb01197.x Patarroyo M, Makgoba W (1989) Leukocyte adhesion to cells, molecular basis, physiological relevance and abnormalities. Scand J Immunol 30:129?164 

  34. Eur J Immunol H Pircher 16 172 1986 10.1002/eji.1830160212 Pircher H, Groscurth P, Baumhutter S, Aguet M, Zinkernagel RM, Hengartner H (1986) A monoclonal antibody against altered LFA-1 induced proliferation and lymphokine release of cloned T cells. Eur J Immunol 16:172?181 

  35. Int J Cancer L Rivoltini 47 746 1991 10.1002/ijc.2910470521 Rivoltini L, Cattoretti G, Arienti F, Mastroianni A, Melani C, Colombo MP, Parmiani G (1991) The high lysability by LAK cells for colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, IFA-3, NCA and a less-differentiated phenotype. Int J Cancer 47:746?754 

  36. J Immunol L Rothlein 141 1665 1988 10.4049/jimmunol.141.5.1665 Rothlein L, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ (1988) Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by proinflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol 141:1665?1669 

  37. Science J Spits 232 403 1986 10.1126/science.3485822 Spits J, Van Schooten W, Keiser H, Van Seventer G, Van de Rijn M, Terhorst C, De Vries DE (1986) Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science 232:403?405 

  38. Cell B Stockinger 56 683 1989 10.1016/0092-8674(89)90590-4 Stockinger B, Pessara U, Lin RW, Habicht J, Grez M, Koch N (1989) A role of Ia-associated invariant chains in antigen processing and presentation. Cell 56:683?689 

  39. Nature MT Sweetser 342 180 1989 10.1038/342180a0 Sweetser MT, Morrison LA, Braciale VL, Braciale TJ (1989) Recognition of pre-processed endogenous antigen by class-I but not class-II MHC-restricted T cells. Nature 342:180?182 

  40. Int J Cancer Y Tomita 46 1001 1990 10.1002/ijc.2910460609 Tomita Y, Nishiyama T, Watanabe H, Fujiwara M, Sato S (1990) Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses. Int J Cancer 46:1001?1006 

  41. Int J Cancer W Vogetseder 43 768 1989 10.1002/ijc.2910430504 Vogetseder W, Feitinger H, Schulz TF, Schwaeble W, Tabaczewski P, Mitterer M, Böck G, Marth C, Dapunt O, Mikuz G, Dierich MP (1989) Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinoma and their stromal fibroblasts. Int J Cancer 43:768?773 

  42. Adv Immunol RM Zinkernagel 27 51 1979 10.1016/S0065-2776(08)60262-X Zinkernagel RM, Doherty PC (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function, and responsiveness. Adv Immunol 27:51?177 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로